Helsinki-based VC Maki.vc is poised to reach the final close of its second fund at €100 million, with the aim to invest in seed-stage startups across Europe. The first investments from the new fund include UK-based Baseimmune (antigen discovery and vaccine design), Volare (Foodtech), and PixieRay (adaptive eyeglasses). Maki.vc’s initial ticket sizes range from €250,000 […]
